Trimovate Cream

How to order Trimovate Cream

1. Find the drug you need on our site.
2. Pick a clinic. See the price.
3. Fill in a short health form.
4. A doctor reads your form.
5. If it is safe for you, they say yes.
6. Your order ships fast to your door.
7. It comes in a plain, sealed box.

Why use us? We compare UK clinics. We show you the price and how fast they ship. We do not sell drugs. We just help you find the best one for you.

Is it safe? Yes. All our clinics are UK-based. A real doctor reads each form. They will not sell to you if it is not safe for you.

Trimovate Cream on Prescriptsy

Trimovate Cream is described on Prescriptsy as independent product information.

Here you can understand how online consultation works, what medical checks partner clinics carry out, and which factors matter when comparing providers.

We do not sell medicines directly, but help users compare licensed healthcare partners on price, delivery speed, service quality, and overall trustworthiness.

Trimovate Cream is a prescription-only topical preparation combining three active ingredients: clobetasone butyrate 0.05% (a moderately potent corticosteroid), oxytetracycline 3% (a tetracycline antibiotic), and nystatin 100,000 units per gram (a polyene antifungal).

This triple-action formulation is designed for the short-term treatment of inflamed skin conditions where bacterial or candidal infection is present or suspected.

Common clinical indications include infected eczema, infected contact dermatitis, infected intertrigo, infected insect bites, and other inflammatory dermatoses complicated by secondary infection.

Skin infections complicating inflammatory dermatoses are common in UK clinical practice.

Patients with eczema are particularly susceptible to bacterial colonisation and infection, most frequently by Staphylococcus aureus, which is found on the skin of approximately 90% of atopic eczema patients.

Candidal superinfection occurs most commonly in moist, occluded skin folds such as the groin, axillae, submammary area, and interdigital spaces.

This page provides a comprehensive clinical overview of how Trimovate works, how to apply it correctly, its side effects, safety warnings, and how to obtain a prescription in the UK.

Important safety information about Trimovate Cream

Before reading further, note the following key safety points about Trimovate Cream.

• Do not use Trimovate for longer than 7 days without medical review. Prolonged use can cause skin thinning, stretch marks, and other corticosteroid side effects.
• Do not apply to the face, groin, or armpits unless specifically instructed by your prescriber.
• Do not use on viral skin infections such as cold sores, chickenpox, or shingles.
• Do not cover the treated area with airtight dressings or bandages unless directed by your doctor.

Understanding infected inflammatory skin conditions

Inflammatory skin conditions such as eczema (atopic dermatitis), contact dermatitis, and seborrhoeic dermatitis impair the skin's barrier function, allowing microorganisms to colonise and infect the damaged skin surface.

This process is known as secondary infection or superinfection. The most common bacterial pathogen involved is Staphylococcus aureus, which produces toxins and superantigens that exacerbate the underlying inflammation.

Streptococcus pyogenes (group A streptococcus) is another common cause. Candidal infection tends to occur in warm, moist skin folds where the environment favours yeast overgrowth.

Signs of secondary infection in an existing skin condition include increased redness, swelling, warmth, pain, weeping, crusting (especially golden-yellow crusting characteristic of impetigo), satellite pustules, and failure to respond to emollient and corticosteroid treatment alone.

When both bacterial and candidal infection are suspected, a combination product such as Trimovate, which addresses inflammation, bacteria, and yeast simultaneously, may be more practical than applying multiple separate agents.

Prevalence in the UK

Atopic eczema affects approximately 1 in 5 children and 1 in 12 adults in the United Kingdom.

NICE estimates that around 30% of eczema flares involve clinically apparent bacterial infection, though subclinical colonisation rates are even higher.

Intertrigo, inflammation of opposing skin folds, is common in obesity, diabetes, and warm humid conditions, and frequently involves both bacterial and candidal organisms.

The demand for effective combination topical treatments that address multiple pathogens alongside inflammation remains high in primary care.

How Trimovate Cream works

Clobetasone butyrate: anti-inflammatory action

Clobetasone butyrate is classified as a moderately potent topical corticosteroid (Group III in the British classification system, between mild agents such as hydrocortisone and potent agents such as betamethasone valerate).

After application to the skin, clobetasone butyrate penetrates the stratum corneum and binds to intracellular glucocorticoid receptors in keratinocytes, fibroblasts, and immune cells.

The activated receptor complex translocates to the nucleus and modulates gene transcription, inducing anti-inflammatory proteins (lipocortins) that inhibit phospholipase A2.

This reduces the synthesis of arachidonic acid and its downstream inflammatory mediators, including prostaglandins and leukotrienes.

The clinical effects include reduced erythema, oedema, pruritus (itching), and vesicle formation.

Clobetasone butyrate has a more favourable safety profile than potent corticosteroids for short-term use, with a lower risk of skin atrophy and systemic absorption when used as directed.

It was specifically developed for use on more sensitive skin areas and for shorter treatment courses, making it suitable for a combination preparation intended for limited duration therapy.

Oxytetracycline: antibacterial action

Oxytetracycline is a broad-spectrum bacteriostatic antibiotic of the tetracycline class.

It inhibits bacterial protein synthesis by reversibly binding to the 30S ribosomal subunit, preventing the attachment of aminoacyl-tRNA to the ribosomal acceptor site.

This blocks the addition of amino acids to the growing peptide chain, halting bacterial growth. Oxytetracycline has activity against many Gram-positive bacteria (including S.

aureus and streptococci) and some Gram-negative organisms, as well as certain anaerobes, chlamydiae, and mycoplasmas.

In the context of Trimovate, oxytetracycline targets secondary bacterial infection of the inflamed skin, most commonly S. aureus.

Topical antibiotic delivery achieves high local concentrations at the site of infection while minimising systemic exposure and related side effects.

However, prolonged or inappropriate use of topical antibiotics contributes to the development of antibiotic resistance, which is why treatment duration with Trimovate should be kept as short as clinically necessary.

Nystatin: antifungal action

Nystatin is a polyene macrolide antifungal agent derived from Streptomyces noursei.

It binds irreversibly to ergosterol, a sterol unique to fungal cell membranes, forming channels or pores that disrupt membrane permeability.

This causes leakage of intracellular contents and fungal cell death. Nystatin is fungicidal against Candida albicans and other Candida species at the concentrations achieved with topical application.

It has no significant activity against bacteria, dermatophytes, or viruses.

Nystatin is not absorbed through intact or damaged skin in clinically significant amounts, making systemic toxicity virtually impossible with topical use.

Clinical evidence and guidelines

The use of combination corticosteroid-antimicrobial preparations for infected inflammatory dermatoses is well-established in UK dermatological practice.

The British Association of Dermatologists (BAD) and NICE CKS guidelines on atopic eczema recognise the need for short-course antimicrobial treatment when secondary infection complicates eczema flares.

While plain emollients and corticosteroids form the backbone of eczema management, the addition of a topical antimicrobial is appropriate when clinical signs of infection are present.

NICE CKS advises that topical antibiotics should not be used routinely for eczema maintenance, as this promotes resistance.

They should be reserved for clinically infected eczema and used for the shortest effective duration, typically no more than 7 to 14 days.

When both bacterial and candidal infection are suspected, combination agents such as Trimovate offer the advantage of a single preparation, improving adherence and simplifying the treatment regimen.

For extensive or severe infection, systemic antibiotics (such as flucloxacillin for staphylococcal infection) may be required and Trimovate alone would not be sufficient.

How to apply Trimovate Cream

Before applying Trimovate, wash your hands and gently cleanse the affected area if possible, then pat dry.

Squeeze a small amount of cream from the tube (using the fingertip unit system as a guide) and apply a thin layer to the affected area.

Gently rub the cream into the skin until it is absorbed. Wash your hands after application unless the hands themselves are being treated.

Apply Trimovate two to four times daily, or as directed by your prescriber.

Begin with the higher frequency during the initial treatment phase and reduce to twice daily as the condition improves.

Do not apply more than the prescribed amount, as this does not increase efficacy but does increase the risk of side effects.

Do not use Trimovate continuously for more than 7 days without review.

Fingertip units explained

One fingertip unit (FTU) is the amount of cream or ointment squeezed from a standard tube along the length of an adult index fingertip, from the tip to the first crease.

One FTU is approximately 0.5 grams and covers an area of skin approximately twice the size of an adult hand (both the palm and fingers).

The FTU system helps ensure that patients apply a consistent and appropriate amount: enough for therapeutic benefit but not so much that absorption and side-effect risk increase unnecessarily.

Where to apply and where to avoid

Trimovate is suitable for use on the trunk, limbs, and skin folds where infected inflammatory dermatoses commonly occur.

It should not be applied to the face, periocular area (around the eyes), genital area in children, or large areas of broken skin without specific medical direction.

Thin skin areas such as the inner arms, backs of the knees, and inguinal folds are more susceptible to corticosteroid side effects.

In these regions, application should be limited in both duration and frequency.

Side effects of Trimovate Cream

Local side effects

Mild burning, stinging, or itching at the application site may occur when Trimovate is first applied, particularly to inflamed or broken skin.

This usually subsides within a few minutes. If irritation persists or worsens, discontinue use and consult your prescriber. Skin dryness and peeling may also occur.

Contact sensitisation to oxytetracycline, although uncommon, may manifest as worsening dermatitis at the treatment site and should prompt discontinuation and patch testing.

Corticosteroid-related effects

With prolonged or excessive use, clobetasone butyrate can cause local skin changes including thinning (atrophy), striae (irreversible stretch marks), telangiectasia (visible spider-like blood vessels), acneiform eruptions, perioral dermatitis, and depigmentation.

The risk increases with occlusion, application to thin skin areas, and use in children.

Systemic absorption is low with short-term appropriate use but can become clinically significant if Trimovate is used over large body surface areas, under dressings, or for extended periods.

Systemic effects include HPA axis suppression, Cushingoid features, hyperglycaemia, and growth retardation in children.

Antibiotic-related effects

Oxytetracycline may cause photosensitivity in the treated area, increasing vulnerability to sunburn from ultraviolet exposure.

Avoid exposing treated skin to direct sunlight or sunlamps during and shortly after treatment.

Prolonged use of topical oxytetracycline may select for resistant organisms, undermining the effectiveness of future antibiotic treatment. This is a further reason to limit treatment duration.

When to seek medical advice

Consult your GP or NHS 111 if your skin condition worsens, if you develop new blistering or widespread redness, if you notice thinning or stretch marks, or if the infection does not respond to treatment within 7 days.

Seek urgent medical advice if you develop signs of a widespread or systemic infection such as fever, malaise, or rapidly spreading redness with warmth and pain (suggesting cellulitis).

Report any suspected adverse reactions via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk .

Warnings and precautions

Contraindications

Do not use Trimovate if you have a known allergy to clobetasone butyrate, oxytetracycline, nystatin, or any other ingredient in the cream.

Do not use on primary skin infections caused by viruses (herpes simplex, varicella, herpes zoster), fungi other than Candida (such as dermatophyte tinea infections, which require specific antifungal treatment), or parasites (such as scabies).

Trimovate is not appropriate for acne vulgaris, rosacea, or perioral dermatitis, as corticosteroids can worsen these conditions.

Do not apply to leg ulcers, as the risk of sensitisation and resistance is high in chronic wounds.

Children and infants

Particular caution is needed in paediatric use. Children have a larger body surface area relative to body weight, resulting in proportionally greater systemic corticosteroid absorption.

Nappies and plastic pants act as occlusive dressings. Trimovate should not be used under nappies for prolonged periods.

Growth monitoring is advisable in any child requiring repeated courses of topical corticosteroids.

Pregnancy and breastfeeding

The safety of Trimovate during pregnancy and breastfeeding has not been fully established. Animal studies with corticosteroids have shown reproductive toxicity, including cleft palate, at high systemic exposures.

Topical use in pregnancy should be limited to situations where the expected benefit clearly outweighs any potential risk, and the lowest effective amount should be used for the shortest possible time.

If Trimovate is applied to the breast area during breastfeeding, the cream must be removed before feeding to prevent the infant from ingesting the active ingredients.

How to obtain Trimovate Cream in the UK

Trimovate Cream is classified as a prescription-only medicine (POM) and is not available over the counter.

You can obtain a prescription from your GP, a dermatologist, or an authorised online prescriber registered with the General Pharmaceutical Council (GPhC).

Your clinician will assess the skin condition, determine whether secondary infection is likely, and decide whether Trimovate or an alternative is most appropriate.

The standard NHS prescription charge in England is currently 9.90 pounds per item; prescriptions are free in Scotland, Wales, and Northern Ireland.

Caring for inflamed and infected skin

In addition to using Trimovate as prescribed, good general skin care supports healing and reduces the risk of reinfection.

Use a fragrance-free emollient (moisturiser) regularly to maintain the skin barrier, even when the infection has resolved.

Avoid soap, bubble bath, and shower gels that strip natural skin oils; use a soap substitute or emollient wash instead.

Wear soft, breathable clothing (cotton is ideal) and avoid scratching, which introduces bacteria and delays healing.

Keep fingernails short and clean to minimise the risk of secondary bacterial inoculation from scratching.

If recurrent infected eczema is a problem, your GP may arrange swabs for culture and sensitivity to guide future antibiotic choices and check for carriage of resistant organisms.

When to seek urgent medical advice

Contact your GP or NHS 111 if your skin condition is getting worse despite treatment, or if new areas of skin become inflamed or infected.

Attend A&E or call 999 if you develop signs of a severe skin infection such as spreading redness and warmth with fever (cellulitis or erysipelas), red streaking along a limb (lymphangitis), or fluid-filled blisters with systemic illness.

Report any suspected adverse reactions to Trimovate via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk .

Sources

• Trimovate Cream, Summary of Product Characteristics (EMC)
• Clobetasone Butyrate, British National Formulary (BNF)
• Eczema (Atopic), NICE CKS
• Atopic Eczema, NHS
• MHRA Yellow Card Scheme